PACIRA BIOSCIENCES, INC. Non Peo Neo Avg Comp Actually Paid Amt
PACIRA BIOSCIENCES, INC. (PCRX) reported Non Peo Neo Avg Comp Actually Paid Amt of $3.48 million for the 12-month period ending 2025-12-31, per its DEFC14A filed 2026-04-28.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-04-28
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2025-12-31 | $3.48M DEFC14A · filed 2026-04-28 |
| 2024-12-31 | $1.64M DEFC14A · filed 2026-04-28 |
| 2023-12-31 | $1.14M DEFC14A · filed 2026-04-28 |
| 2022-12-31 | $910.11K DEFC14A · filed 2026-04-28 |
| 2021-12-31 | $1.81M DEFC14A · filed 2026-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |